Sterilization Equipment Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$2500
Buy Report View Sample

Published: October 29, 2021 Report Code: GDME1186EPD-ST

Select Item

Sterilization equipment is used to kill all the microbes (sterilization) from objects. On the basis of application, sterilization is of three types: physical, chemical and ultraviolet. GlobalData's Medical Devices sector report, “Sterilization Equipment (General Surgery) – Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Sterilization Equipment pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

The Sterilization Equipment report provides key information and data related to:
Extensive coverage of the Sterilization Equipment under development
Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates
Reviews of major players involved in the pipeline product development.
Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and, the number of trials of the major Sterilization Equipment pipeline products.
Review of Recent Developments in the segment / industry
The Sterilization Equipment report enables you to:
Access significant competitor information, analysis, and insights to improve your R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Sterilization Equipment under development
Formulate market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
The GlobalData Differentiation

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

The data and analysis within this report are driven by GlobalData Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:

• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025
• 6,700+ industry-leading analysis reports covering sector reports, medipoint reports, country analysis, expert insights and industry analysis (devices and procedures) reports
• 64,000+ medical equipment company profiles
• 5,600+ company profiles of medical equipment manufacturers in China and India
• 2,200+ company profiles of medical equipment manufacturers in Japan
• 1,200+ companies’ revenue splits and market shares
• 1,600+ quarterly and annual medical equipment company financials
• 850+ medical equipment company SWOTs
• 28,000+ pipeline product profiles
• 56,400+ marketed product profiles
• 47,000+ clinical trials
• 41,500+ trial investigators
• 7,000+ reports on companies with products in development
• 44,000+ deals in the medical equipment industry
• 1,100+ surgical and diagnostic procedures by therapy area
• 50+ key healthcare indicators by country
• 431,000+ Themes Content Items
• 600+ Influencers
• 1,900+ Analysts & Researchers
• 0.5m+ Community Members
• 141,000+ Macroeconomic Indicators
• 1,013,000+ City Indicators

For more information or to receive a free demonstration of the service, please visit:
https://medical.globaldata.com/home.aspx
Custom Requirements
Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.

Scope

– Extensive coverage of the Sterilization Equipment under development

– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

– The report reviews the major players involved in the development of Sterilization Equipment and list all their pipeline projects

– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

– The report provides key clinical trial data of ongoing trials specific to pipeline products

– Recent developments in the segment / industry

Reasons to Buy

The report enables you to:

– Formulate significant competitor information, analysis, and insights to improve R&D strategies

– Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage

– Identify and understand important and diverse types of Sterilization Equipment under development

– Develop market-entry and market expansion strategies

– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

– In-depth analysis of the product’s current stage of development, territory and estimated launch date

Advanced Sterilization Products Services Inc
B.B.R. Medical Innovations
Inc.
Brighton Development LLC
Case Western Reserve University
Creo Medical Ltd
EGOHEALTH
HyperMed Inc
Indian Institute of Technology Ropar
Iowa State University
JJGC Industria e Comercio De Materiais Dentarios SA
MicroGo LLP
National Cheng-Kung University Hospital
Oklahoma State University
PuraCath Medical
Inc.
Resultados y Calidad del Sistema Sanitario Publico de Andalucia
RSO Shift GmbH
SpineEX Inc
SteriFre Inc
Sterilucent Inc
Sterilux SA
Tso3 Inc
University of Florida
University of Minnesota
University of Oxford
Verrix LLC

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 7

|1.2 List of Figures 9

2 Introduction 10

2.1 Sterilization Equipment Overview 10

3 Products under Development 11

3.1 Sterilization Equipment – Pipeline Products by Stage of Development 11

3.2 Sterilization Equipment – Pipeline Products by Segment 12

3.3 Sterilization Equipment – Pipeline Products by Territory 13

3.4 Sterilization Equipment – Pipeline Products by Regulatory Path 14

3.5 Sterilization Equipment – Pipeline Products by Estimated Approval Date 15

4 Sterilization Equipment – Pipeline Products under Development by Companies 16

4.1 Sterilization Equipment Companies – Pipeline Products by Stage of Development 16

4.2 Sterilization Equipment – Pipeline Products by Stage of Development 17

5 Sterilization Equipment Companies and Product Overview 18

5.1 Advanced Sterilization Products Services Inc Company Overview 18

5.1.1 Advanced Sterilization Products Services Inc Pipeline Products & Ongoing Clinical Trials Overview 18

5.2 B.B.R. Medical Innovations, Inc. Company Overview 20

5.2.1 B.B.R. Medical Innovations, Inc. Pipeline Products & Ongoing Clinical Trials Overview 20

5.3 Brighton Development LLC Company Overview 21

5.3.1 Brighton Development LLC Pipeline Products & Ongoing Clinical Trials Overview 21

5.4 Case Western Reserve University Company Overview 22

5.4.1 Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview 22

5.5 Creo Medical Ltd Company Overview 23

5.5.1 Creo Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 23

5.6 EGOHEALTH Company Overview 24

5.6.1 EGOHEALTH Pipeline Products & Ongoing Clinical Trials Overview 24

5.7 HyperMed Inc Company Overview 25

5.7.1 HyperMed Inc Pipeline Products & Ongoing Clinical Trials Overview 25

5.8 Indian Institute of Technology Ropar Company Overview 26

5.8.1 Indian Institute of Technology Ropar Pipeline Products & Ongoing Clinical Trials Overview 26

5.9 Iowa State University Company Overview 27

5.9.1 Iowa State University Pipeline Products & Ongoing Clinical Trials Overview 27

5.10 JJGC Industria e Comercio De Materiais Dentarios SA Company Overview 28

5.10.1 JJGC Industria e Comercio De Materiais Dentarios SA Pipeline Products & Ongoing Clinical Trials Overview 28

5.11 MicroGo LLP Company Overview 29

5.11.1 MicroGo LLP Pipeline Products & Ongoing Clinical Trials Overview 29

5.12 National Cheng-Kung University Hospital Company Overview 30

5.12.1 National Cheng-Kung University Hospital Pipeline Products & Ongoing Clinical Trials Overview 30

5.13 Oklahoma State University Company Overview 31

5.13.1 Oklahoma State University Pipeline Products & Ongoing Clinical Trials Overview 31

5.14 PuraCath Medical, Inc. Company Overview 32

5.14.1 PuraCath Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 32

5.15 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Company Overview 33

5.15.1 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Pipeline Products & Ongoing Clinical Trials Overview 33

5.16 RSO Shift GmbH Company Overview 34

5.16.1 RSO Shift GmbH Pipeline Products & Ongoing Clinical Trials Overview 34

5.17 SpineEX Inc Company Overview 35

5.17.1 SpineEX Inc Pipeline Products & Ongoing Clinical Trials Overview 35

5.18 SteriFre Inc Company Overview 36

5.18.1 SteriFre Inc Pipeline Products & Ongoing Clinical Trials Overview 36

5.19 Sterilucent Inc Company Overview 37

5.19.1 Sterilucent Inc Pipeline Products & Ongoing Clinical Trials Overview 37

5.20 Sterilux SA Company Overview 38

5.20.1 Sterilux SA Pipeline Products & Ongoing Clinical Trials Overview 38

5.21 Tso3 Inc Company Overview 39

5.21.1 Tso3 Inc Pipeline Products & Ongoing Clinical Trials Overview 39

5.22 University of Florida Company Overview 40

5.22.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview 40

5.23 University of Minnesota Company Overview 41

5.23.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 41

5.24 University of Oxford Company Overview 42

5.24.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview 42

5.25 Verrix LLC Company Overview 43

5.25.1 Verrix LLC Pipeline Products & Ongoing Clinical Trials Overview 43

6 Sterilization Equipment- Recent Developments 44

6.1 Oct 11, 2021: Johnson & Johnson to Participate in the Credit Suisse 30th Annual Healthcare Conference 44

6.2 Sep 28, 2021: QuVa Pharma Appoints Mr. Talha Ashraf to its Board of Directors as Independent External Director 44

6.3 Sep 27, 2021: Byotrol Announces Annual Report & Accounts and Notice of AGM 44

6.4 Sep 22, 2021: BD completes study investigating performance of glass prefillable syringes (PFS) in deep cold storage 45

6.5 Sep 21, 2021: Östra Hospital’s new CSSD optimizes the surgical instrument workflow 45

6.6 Sep 21, 2021: Ostra Hospital’s new CSSD optimizes the surgical instrument workflow 47

6.7 Sep 16, 2021: Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results 48

6.8 Sep 09, 2021: Boston Scientific Announces 2021 Investor Day Meeting 49

6.9 Sep 08, 2021: Nanosonics announces 2020 Full Year Results Investor Presentation 49

6.10 Sep 08, 2021: Nanosonics Announces 2021 Full Year Investor Presentation 49

6.11 Sep 02, 2021: Hologic to Webcast Presentations at Upcoming Virtual Investor Conferences 49

6.12 Sep 01, 2021: Shandong Weigao Group Medical Polymer Notice of Extraordinary General Meeting and Proposed Interim Dividend 49

6.13 Aug 31, 2021: Endo comments on non-infringement ruling in VASOSTRICT patent litigation 49

6.14 Aug 27, 2021: Shandong Weigao Group Medical Polymer Announcement of Interim Results for the Six Months Ended 30 June 2021 50

6.15 Aug 27, 2021: Shandong Weigao Group Announces Interim Results for the Six Months Ended 30 June 2021 50

6.16 Aug 24, 2021: Nanosonics announces 2021 full year financial results 50

6.17 Aug 19, 2021: Alex Gorsky to Serve as Executive Chairman and Transition Role of Chief Executive Officer of Johnson & Johnson to Joaquin Duato, Effective January 3, 2022 55

6.18 Aug 19, 2021: Byotrol Announces Final Results for the Year Ended 31 March 2021 57

6.19 Aug 14, 2021: Samyak International announce Board Meeting Outcome for Submission Of Unaudited Standalone And Consolidated Financial Results For The 1St Quarter Ended June 30, 2021 58

6.20 Aug 12, 2021: Johnson & Johnson to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference 59

6.21 Aug 11, 2021: Hartmann’s announce Sales and earnings under pressure 59

6.22 Aug 09, 2021: Johnson & Johnson to Participate in Barclays Global Consumer Staples Virtual Conference 60

6.23 Aug 09, 2021: STERIS Announces Financial Results for Fiscal 2022 First Quarter 60

6.24 Aug 05, 2021: Cardinal Health reports fourth quarter and full year results for fiscal year 2021 61

6.25 Aug 05, 2021: Mesa Labs Announces First Quarter Results 64

6.26 Jul 30, 2021: Balchem Reports Second Quarter 2021 Financial Results 68

6.27 Jul 29, 2021: Panasonic announces financial results for three months ended June 30, 2021 68

6.28 Jul 29, 2021: Smith+Nephew Second Quarter and First Half 2021 Results 70

6.29 Jul 29, 2021: Fortive Reports Strong Second Quarter 2021 Results and Raises 2021 Revenue, Operating Profit Margin and EPS Guidance 71

6.30 Jul 29, 2021: BD to Present at UBS Genomics

2.0 and MedTech Innovations Summit 72

6.31 Jul 29, 2021: Smith & Nephew announces Half-year Report 72

6.32 Jul 28, 2021: Balchem to Present at the Jefferies Virtual Industrials Conference August 4, 2021 73

6.33 Jul 28, 2021: Hologic Announces Financial Results for Third Quarter of Fiscal 2021 73

6.34 Jul 28, 2021: CONMED Announces financial results for the second quarter ended June 30, 2021 74

6.35 Jul 28, 2021: 3m announces Half-year Report 78

6.36 Jul 27, 2021: 3M reports second-quarter 2021 results 79

6.37 Jul 27, 2021: Fortive Appoints Olumide Soroye as Leader of Its Intelligent Operating Solutions Segment 80

6.38 Jul 27, 2021: STERIS to Host a Conference Call for Fiscal 2022 First Quarter Financial Results on August 10, 2021 81

6.39 Jul 27, 2021: Johnson & Johnson to Participate in the Virtual Wells Fargo Healthcare Conference 81

6.40 Jul 21, 2021: Johnson & Johnson Reports 2021 Second-Quarter Results 81

6.41 Jul 16, 2021: Balchem Announces Conference Call for 2nd Quarter 2021 Financial Results 82

6.42 Jul 15, 2021: Hogy Medical Announces Q1 financial results 82

6.43 Jul 12, 2021: Fortive Announces Preliminary Financial Information for the Second Quarter 2021 83

6.44 Jul 07, 2021: Timing of Smith+Nephew Second Quarter Trading and First Half 2021 Results 83

6.45 Jun 30, 2021: Samyak International Announces Audited Standalone And Consolidated Financial Results For The Financial Year Ended March 31, 2021 83

6.46 Jun 30, 2021: Tristel : Positive signs of recovery in out-patient departments and continued growth in surface disinfectant product sales 83

6.47 Jun 30, 2021: Balchem Reports Record Second Quarter Sales of $202.4 Million, Net Earnings of $22.7 Million, GAAP EPS of $0.70, and Adjusted EPS of $0.93 85

6.48 Jun 28, 2021: Nanosonics to launch new infection prevention digital product platform, Nanosonics AuditPro, for traceability, reporting and compliance 85

6.49 Jun 09, 2021: Boulder iQ sterilization business receives $250,000 grant, helps medical devices get to market faster 86

6.50 Jun 04, 2021: Getinge grows with social funding 87

6.51 May 26, 2021: Hogy Medical: Notice of Convocation of the 60th Ordinary General Meeting of Shareholders 88

6.52 May 24, 2021: Boston Scientific to Participate in Bernstein's 37th Annual Strategic Decisions Conference 88

6.53 May 20, 2021: Getinge Flow Family Anesthesia machines awarded contract with Vizient 88

6.54 May 18, 2021: Balchem to Present at the Stephens Food & Ag Disrupted: Public-Private Conference on May 25, 2021 88

6.55 May 18, 2021: STERIS Announces Financial Results for Fiscal 2021 Fourth Quarter and Full Year 88

6.56 May 14, 2021: Christopher Lathan named chief clinical access and equity officer at Dana-Farber 90

6.57 May 11, 2021: ADDvise received order worth SEK 9 million 90

6.58 May 11, 2021: STERIS Announces Changes to Board 90

6.59 May 10, 2021: Panasonic makes board of directors changes 91

6.60 May 10, 2021: Panasonic Announces Fiscal 2021 Annual Results 91

6.61 May 06, 2021: Cardinal Health reports third-quarter results for fiscal year 2021 91

6.62 Apr 30, 2021: Balchem Reports Record First Quarter Sales of $185.7 Million, Net Earnings of $23.4 Million, GAAP EPS of $0.72, and Adjusted EPS of $0.87 93

6.63 Apr 29, 2021: Fortive Reports Strong First Quarter 2021 Results; Raises Full-Year 2021 Revenue and EPS Guidance 94

6.64 Apr 28, 2021: CONMED Announces First Quarter Financial Results 95

6.65 Apr 28, 2021: Hologic Announces Financial Results for Second Quarter of Fiscal 2021 96

6.66 Apr 28, 2021: 3M announce 1st Quarter Results 97

6.67 Apr 27, 2021: Shandong Weigao Group Medical Polymer notice of annual general meeting 97

6.68 Apr 27, 2021: STERIS Announces Preliminary Financial Results for Fiscal 2021 98

6.69 Apr 15, 2021: Darnitsa increases the amount of recyclable waste 99

6.70 Apr 12, 2021: Nanosonics announces 2020 Half Year Financial Results 99

6.71 Apr 12, 2021: Johnson & Johnson to Participate in the BofA Securities Virtual 2021 Healthcare Conference 99

6.72 Apr 05, 2021: BD To Announce Financial Results For Its Second Quarter Of Fiscal 2021 99

6.73 Apr 01, 2021: Panasonic appoints Yuki Kusumi as chief executive officer 100

6.74 Apr 01, 2021: Fortive Schedules First Quarter 2021 Earnings Conference Call 100

6.75 Apr 01, 2021: CONMED to Announce First Quarter 2021 Financial Results on April 28, 2021 101

6.76 Apr 01, 2021: QuVa Pharma Expands Leadership Team with Appointment of Industry Veteran Scott Aladeen as Chief Operating Officer 101

6.77 Mar 30, 2021: Shandong Weigao Group Medical Polymer Announces Annual Results for the Year Ended 31 December 2020 102

6.78 Mar 30, 2021: Shandong Weigao Appointment And Resignation Of Directors, Re-Election of Retiring Independent Non-Executive Directors and Change Of Chairman Of The Board, CEO 102

6.79 Mar 30, 2021: Advanced Sterilization Products Announces Aisha Barry as President 104

6.80 Mar 29, 2021: Hyalo Technologies unveils new technology making drug molecules stable at room temperature preventing the need for cold chain storage and distribution 104

6.81 Mar 23, 2021: CONMED Announces Annual Meeting of Stockholders 105

6.82 Mar 22, 2021: QuVa Pharma participates in Wall Street Journal's Health Forum 105

6.83 Mar 11, 2021: Darnitsa launched Facebook tours of the production facilities 105

6.84 Mar 08, 2021: U of M Vice President for Research Chris Cramer announces departure from the University for national research opportunity 106

6.85 Mar 08, 2021: Shandong Weigao Group Medical Polymer announces POLL RESULTS FOR THE EXTRAORDINARY GENERAL MEETING HELD ON 8 MARCH 2021 107

6.86 Feb 25, 2021: Cantel Medical to Hold Conference Call to Discuss Results for its Second Quarter Ended January 31, 2021 107

6.87 Feb 22, 2021: Tristel Announces Unaudited Interim Results for the six months ended 31 December 2020 107

6.88 Feb 19, 2021: Balchem reports record fourth quarter sales of $180.7 million and net earnings of $22.2 million, GAAP EPS of $0.68 and adjusted EPS of $0.83 108

6.89 Feb 19, 2021: Balchem Reports Fourth Quarter 2020 Financial Results 110

6.90 Feb 18, 2021: Smith+Nephew Fourth Quarter and Full Year 2020 Results 110

6.91 Feb 18, 2021: Vested Medical / OrthoIllinois completes successful pilot of off-site sterilization processing 114

6.92 Feb 18, 2021: Balchem Corporation to participate in H.C. Wainwright Fireside Chat on February 24, 2021 115

6.93 Feb 17, 2021: U of M’s Technological Leadership Institute names Professor Allison Hubel new director 115

6.94 Feb 17, 2021: Medtronic Executives to Speak at Upcoming Investor Conferences 116

6.95 Feb 16, 2021: Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2021 117

6.96 Feb 16, 2021: CONMED Corporation to Participate in a Virtual Fireside Chat at the SVB Leerink Global Healthcare Conference 117

6.97 Feb 13, 2021: Samyak International Announces Unaudited standalone and consolidated financial results of the company for the Quarter and Nine Month ended December 31,2020 117

6.98 Feb 12, 2021: BD to Present at Upcoming Investor Conferences 117

6.99 Feb 12, 2021: Boston Scientific Announces February and March 2021 Conference Schedule 118

6.100 Feb 10, 2021: Hologic to Webcast Presentations at Upcoming Virtual Investor Conferences 118

6.101 Feb 08, 2021: Darnitsa is the first Ukrainian company to join The Regulatory Affairs Professionals Society 118

6.102 Feb 05, 2021: Cardinal Health Reports Second-Quarter Results for Fiscal Year 2021 118

6.103 Feb 05, 2021: Balchem Corporation Announces Quarterly Conference Call for Fourth Quarter Financial Results on February 19, 2021 119

6.104 Feb 04, 2021: Fortive Reports Fourth Quarter 2020 Results 120

6.105 Feb 04, 2021: Cardinal Health Earnings Preview 120

6.106 Feb 03, 2021: Steris PLC President, CEO Rosebrough Stepping Down in July 121

6.107 Feb 02, 2021: Jim Fitterling elected to 3M board of directors 121

6.108 Feb 01, 2021: Girls Inc. Of Chattanooga Appoints Toccora Johnson As New CEO 121

6.109 Jan 27, 2021: Hologic FQ1 2021 Earnings Preview 121

6.110 Jan 19, 2021: STERIS to Host a Conference Call for Fiscal 2021 Third Quarter Financial Results on February 3, 2021 121

6.111 Jan 15, 2021: UVDI's device neutralises SARS-CoV-2 within five minutes in hospitals 122

6.112 Jan 13, 2021: Intuitive Announces Preliminary Fourth Quarter and Full Year 2020 Results 122

6.113 Jan 07, 2021: STERIS To Participate in Upcoming Investor Conferences 124

6.114 Jan 07, 2021: Balchem to Present at Sidoti & Company Virtual Investor Conference on January 13th, 2021 124

6.115 Dec 24, 2020: Tristel: Announces appointment of Caroline Stephens to the Board 124

6.116 Dec 18, 2020: Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results 124

6.117 Dec 07, 2020: Byotrol announces interim results for the six months ended 30 September 2020 125

6.118 Nov 24, 2020: Cantel Medical to Hold Conference Call to Discuss Results for its First Quarter Ended October 31, 2020 125

6.119 Nov 03, 2020: Balchem to Present at Stephens Annual Investment Conference 2020 on November 17, 2020 126

6.120 Oct 29, 2020: Balchem to Present at Baird’s 2020 Global Industrial Conference November 12, 2020 126

6.121 Oct 28, 2020: Balchem reports record third quarter sales of $175.1 million, net earnings of $21.6 million, GAAP EPS of $0.66, and Adjusted EPS of $0.83 126

7 Appendix 129

7.1 Methodology 129

7.2 About GlobalData 132

7.3 Contact Us 132

Table

Sterilization Equipment – Pipeline Products by Stage of Development 11

Sterilization Equipment – Pipeline Products by Segment 12

Sterilization Equipment – Pipeline Products by Territory 13

Sterilization Equipment – Pipeline Products by Regulatory Path 14

Sterilization Equipment – Pipeline Products by Estimated Approval Date 15

Sterilization Equipment Companies – Pipeline Products by Stage of Development 16

Sterilization Equipment – Pipeline Products by Stage of Development 17

Advanced Sterilization Products Services Inc Pipeline Products & Ongoing Clinical Trials Overview 18

GLOSAIR 600 System – Product Status 18

GLOSAIR 600 System – Product Description 18

STERRAD NX Sterilizer with ALLClear Technology – Product Status 19

STERRAD NX Sterilizer with ALLClear Technology – Product Description 19

B.B.R. Medical Innovations, Inc. Pipeline Products & Ongoing Clinical Trials Overview 20

Inline IV Fluid Sterilizer – Product Status 20

Inline IV Fluid Sterilizer – Product Description 20

Brighton Development LLC Pipeline Products & Ongoing Clinical Trials Overview 21

Self Sterilizing Bag – Product Status 21

Self Sterilizing Bag – Product Description 21

Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview 22

Port Sterilizer – Product Status 22

Port Sterilizer – Product Description 22

Creo Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 23

CRoMa System – Plasma Sterilization – Product Status 23

CRoMa System – Plasma Sterilization – Product Description 23

EGOHEALTH Pipeline Products & Ongoing Clinical Trials Overview 24

UVeye – Product Status 24

UVeye – Product Description 24

HyperMed Inc Pipeline Products & Ongoing Clinical Trials Overview 25

UVG Device – Product Status 25

UVG Device – Product Description 25

Indian Institute of Technology Ropar Pipeline Products & Ongoing Clinical Trials Overview 26

UV-C Sterilization System – Product Status 26

UV-C Sterilization System – Product Description 26

Iowa State University Pipeline Products & Ongoing Clinical Trials Overview 27

Disinfecting Device – Surgical Mesh – Product Status 27

Disinfecting Device – Surgical Mesh – Product Description 27

JJGC Industria e Comercio De Materiais Dentarios SA Pipeline Products & Ongoing Clinical Trials Overview 28

NUVO Instrument Kit Case – Product Status 28

NUVO Instrument Kit Case – Product Description 28

MicroGo LLP Pipeline Products & Ongoing Clinical Trials Overview 29

Portable Sterilizer – Product Status 29

Portable Sterilizer – Product Description 29

National Cheng-Kung University Hospital Pipeline Products & Ongoing Clinical Trials Overview 30

Pen-Size Plasma Sterilization Device – Product Status 30

Pen-Size Plasma Sterilization Device – Product Description 30

Oklahoma State University Pipeline Products & Ongoing Clinical Trials Overview 31

Plasma Pouch – Product Status 31

Plasma Pouch – Product Description 31

PuraCath Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 32

Catheter Disinfection System – Product Status 32

Catheter Disinfection System – Product Description 32

Resultados y Calidad del Sistema Sanitario Publico de Andalucia Pipeline Products & Ongoing Clinical Trials Overview 33

Insulating Container – Product Status 33

Insulating Container – Product Description 33

RSO Shift GmbH Pipeline Products & Ongoing Clinical Trials Overview 34

LifeShift Sterilizer – Product Status 34

LifeShift Sterilizer – Product Description 34

SpineEX Inc Pipeline Products & Ongoing Clinical Trials Overview 35

HERCULAES Sterilization Container – Product Status 35

HERCULAES Sterilization Container – Product Description 35

SteriFre Inc Pipeline Products & Ongoing Clinical Trials Overview 36

Sterifre Countertop Sterilizer – Product Status 36

Sterifre Countertop Sterilizer – Product Description 36

Sterilucent Inc Pipeline Products & Ongoing Clinical Trials Overview 37

Sterilucent MSD – Product Status 37

Sterilucent MSD – Product Description 37

Sterilux SA Pipeline Products & Ongoing Clinical Trials Overview 38

Sterilux V1 – Product Status 38

Sterilux V1 – Product Description 38

Tso3 Inc Pipeline Products & Ongoing Clinical Trials Overview 39

STERIZONE VP4 Sterilizer With Double-Door Option – Product Status 39

STERIZONE VP4 Sterilizer With Double-Door Option – Product Description 39

University of Florida Pipeline Products & Ongoing Clinical Trials Overview 40

Self-Sterilizing Device – Product Status 40

Self-Sterilizing Device – Product Description 40

University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 41

Infection Control System – Product Status 41

Infection Control System – Product Description 41

University of Oxford Pipeline Products & Ongoing Clinical Trials Overview 42

SibSpark Microplasma Sterilisation Device – Product Status 42

SibSpark Microplasma Sterilisation Device – Product Description 42

Verrix LLC Pipeline Products & Ongoing Clinical Trials Overview 43

Verrix EVA System – Product Status 43

Verrix EVA System – Product Description 43

Figures

Sterilization Equipment – Pipeline Products by Stage of Development 11

Sterilization Equipment – Pipeline Products by Segment 12

Sterilization Equipment – Pipeline Products by Territory 13

Sterilization Equipment – Pipeline Products by Regulatory Path 14

Frequently asked questions

Sterilization Equipment Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 standard reports
Currency USD
$2,500

Can be used by individual purchaser only

Most Popular
$5,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$7,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Sterilization Equipment Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more General Surgery reports
Medical Devices
New
PTA Peripheral DCB Catheters Pipeline by Development Stages, Segments, Region…
$4,000 | March 2024
Medical Devices
New
Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Medical Devices
New
PCR Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Sterilization Equipment Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 in real time.

  • Access a live Sterilization Equipment Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more